Apr 04, 2023

G-CON Manufacturing, Inc. Welcomes Anne Jones as New President and CEO

G-CON Manufacturing Inc., the global leader in off-site prefabricated cleanroom systems, today announced that Dr. Anne Jones has been appointed as President and Chief Executive Officer, effective immediately. Anne brings over 25 years of management experience, having led businesses and teams in life sciences, healthcare and cell therapy companies. She takes over following the retirement of G-CON’s long-time CEO, Maik Jornitz.

“Under Maik’s leadership, G-CON has grown to be the industry leader for prefabricated cleanrooms, and we thank Maik for his contributions to the team and the industry,” said Gus Salem, Chair of G-CON’s board of directors. “The board is excited to welcome Anne to lead this company in its important next phase of growth. She is a proven business leader with a demonstrated track history in leading and scaling businesses in diverse markets.”

Prior to G-CON, Dr. Jones held leadership positions at Pall Corporation (Danaher), Agilent Technologies and GE Healthcare Life Sciences (now Cytiva), as well as holding C-suite positions at genomics and cell therapy innovator companies. Anne’s broad experiences include general management, strategy, and business development, as well as COO and CBO roles. Anne will lead G-CON through its next phase of growth, focused on serving its global client base, reinforcing its product offering, and exploring new areas for expansion of the business.

“I am honored to lead the talented team at G-CON and to continue scaling and growing this business,” commented Jones. “This company serves a breadth of cleanroom markets and is uniquely positioned to enable solutions that accelerate the provision of emerging drug modalities including mRNA vaccines and cell and gene therapies to patients. G-CON’s strong history in delivery of cleanroom PODs across pharma, biotech, and CDMO customers has been proven to bring new FDA-cleared medicines to market quickly and efficiently.”

About G-CON Manufacturing

G-CON builds PODular cleanrooms offsite for innovative biopharmaceutical & pharmaceutical companies. Streamlined, offsite building processes enable G-CON to deliver the highest quality cleanroom facilities, quickly and on time. G-CON adapts to unique requirements on every build, delivering projects with our commitment to certainty every time.

About Summa Equity

Summa invests in companies that are solving global challenges and creating positive Environmental, Social, and Governance (ESG) outcomes for society.

Summa’s purpose is to co-create win-win for investors, portfolio companies, and society through aligning its vision and outcomes to the Sustainable Development Goals, ensuring a net-positive impact against ESG challenges, and the potential for long-term, sustainable outperformance.

Investments are focused on industries and companies within three sustainability megatrends: Resource Efficiency, Changing Demographics, and Tech-Enabled Businesses. Across these themes, Summa’s portfolio companies are supporting a world in transition and showing that business can be part of the solution. Summa has more than €1.4bn of assets under management.

For more information contact:
Brittany Berryman
Director of Marketing
G-CON Manufacturing, Inc.
6161 Imperial Loop, College Station, TX 77845
Phone: 979-204-7975
e-mail: bberryman@gconbio.com